As HSP70 and HSP47 are potential targets for the control of liver fibrosis due to their role in the regulation of HSCs activation, collagen synthesis, and fibrogenesis, drugs that inhibit HSP47 or induce HSP70 can be tested for their effectiveness against liver fibrosis, especially for comorbidities. The gene discussed is SERPINH1; the disease is Hepatic fibrosis.